AbbVie will buy Aliada Therapeutics for $1.4 billion in cash, it said on Monday, gaining access to the privately held therapy developer's Alzheimer's disease candidate as the U.S. drugmaker increases ...
New Home-Administered Treatment ... disorders and physical multimorbidity, shedding new light on the health risks faced by people with these conditions. The research ... Exposure Therapy to ...
Body dysmorphia, also called body dysmorphic disorder (BDD), is a mental health ... you find out whether you might have body dysmorphia. Treatment for body dysmorphia likely will include a ...